THTX: Theratechnologies Inc. Company Profile & Statistics

About

Theratechnologies, Inc. is a pharmaceutical company focusing on the development of therapeutic peptide products with an emphasis on growth-hormone releasing factor peptides. It's main product EGRIFTA is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy which is marketed primarily in the United States, Latin America, Africa, the Middle East, Europe, Russia, South Korea, Taiwan, and Thailand. Theratechnologies, Inc. is headquartered in Montreal, Canada.

Info & Links

CEO

Paul Levesque

Headquarters

2015 Peel Street, 11th Floor
MONTREAL, A8 H3A 1T8, CANADA

Auditor

KPMG LLP

Share holders

Employees

103

Theratechnologies Inc. Statistics

Valuation Measures

Market Capitalization²

80.01M

Enterprise Value

102.46M

Enterprise Value/EBITDA(ttm)

8.02

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

0.83

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

76.30%

Operating Margin(ttm)

-3.75%

Profit Margin(ttm)

-5.29%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-6.10%

Return on Assets(ttm)

-4.31%

Income Statement

Revenue(ttm)

84.32M

Revenue Per Share(ttm)

Gross Profit(ttm)

64.90M

EBITDA(ttm)³

12.77M

Net Income Available to Common(ttm)

-3.16M

Diluted EPS(ttm)

-0.10

Share Statistics

Beta (5Y Monthly)

1.42

52-Week Change

3.67%

S&P 500 52-Week Change

24.24%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

Dividend Yield

0.00%

Float⁴

0.00

% Held by Insiders

% Held by Institutions

0.00%

Balance Sheet

Total Cash(mrq)

38.86M

Total Cash Per Share(mrq)

Total Debt(mrq)

57.15M

Total Debt/Equity(mrq)

-290.42%

Current Ratio(mrq)

1.08%

Quick Ratio(mrq)

0.97%

Book Value Per Share(mrq)

-0.43

Cash Flow

Operating Cash Flow Per Share(ytd)

0.05

Free Cash Flow(ytd)

2.61M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

THTX

Theratechnologies Inc.

Theratechnologies Inc. Profile